Abby Jo Lara, APRN | |
500 Clinic Dr, Hopkinsville, KY 42240-4991 | |
(270) 707-3354 | |
(270) 707-3351 |
Full Name | Abby Jo Lara |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 13 Years |
Location | 500 Clinic Dr, Hopkinsville, Kentucky |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003189267 | NPI | - | NPPES |
7100200240 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 3007353 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lifeline Home Health Of Western Ky | Hopkinsville, KY | Home health agency |
Baptist Health Madisonville | Madisonville, KY | Hospital |
Jennie Stuart Medical Center | Hopkinsville, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Baptist Health Deaconess Medical Group Inc | 6103220330 | 126 |
News Archive
Researchers from the Cochrane Infectious Diseases Group, co-ordinated through the editorial base in LSTM, conducted an independent review of the effects of treating cholera with antimicrobial drugs, published in The Cochrane Library today.
Europe must act to prevent new legislation impeding the use of magnetic resonance imaging (MRI) in medical research, diagnosis and treatment, states the European Science Foundation (ESF) in a new report. The report is endorsed by the European Medical Research Councils, representing the medical research communities in 30 countries.
Head and neck abscesses are infrequent complications of upper respiratory infections, but they can occur suddenly and be rapidly progressive. If untreated, the abscesses can lead to airway obstruction, vision loss, intracranial infections, and even death.
ScinoPharm, an active pharmaceutical ingredient specialist, today announced audited record results for its fiscal year 2009. The company posted NT$3.791 billion in revenue, an increase of 20.54% over 2008.
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.
› Verified 4 days ago
Entity Name | Baptist Health Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740586213 PECOS PAC ID: 5597867184 Enrollment ID: O20070228000503 |
News Archive
Researchers from the Cochrane Infectious Diseases Group, co-ordinated through the editorial base in LSTM, conducted an independent review of the effects of treating cholera with antimicrobial drugs, published in The Cochrane Library today.
Europe must act to prevent new legislation impeding the use of magnetic resonance imaging (MRI) in medical research, diagnosis and treatment, states the European Science Foundation (ESF) in a new report. The report is endorsed by the European Medical Research Councils, representing the medical research communities in 30 countries.
Head and neck abscesses are infrequent complications of upper respiratory infections, but they can occur suddenly and be rapidly progressive. If untreated, the abscesses can lead to airway obstruction, vision loss, intracranial infections, and even death.
ScinoPharm, an active pharmaceutical ingredient specialist, today announced audited record results for its fiscal year 2009. The company posted NT$3.791 billion in revenue, an increase of 20.54% over 2008.
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.
› Verified 4 days ago
Entity Name | Baptist Health Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
Researchers from the Cochrane Infectious Diseases Group, co-ordinated through the editorial base in LSTM, conducted an independent review of the effects of treating cholera with antimicrobial drugs, published in The Cochrane Library today.
Europe must act to prevent new legislation impeding the use of magnetic resonance imaging (MRI) in medical research, diagnosis and treatment, states the European Science Foundation (ESF) in a new report. The report is endorsed by the European Medical Research Councils, representing the medical research communities in 30 countries.
Head and neck abscesses are infrequent complications of upper respiratory infections, but they can occur suddenly and be rapidly progressive. If untreated, the abscesses can lead to airway obstruction, vision loss, intracranial infections, and even death.
ScinoPharm, an active pharmaceutical ingredient specialist, today announced audited record results for its fiscal year 2009. The company posted NT$3.791 billion in revenue, an increase of 20.54% over 2008.
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.
› Verified 4 days ago
Entity Name | Baptist Health Deaconess Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437730942 PECOS PAC ID: 6103220330 Enrollment ID: O20210810000993 |
News Archive
Researchers from the Cochrane Infectious Diseases Group, co-ordinated through the editorial base in LSTM, conducted an independent review of the effects of treating cholera with antimicrobial drugs, published in The Cochrane Library today.
Europe must act to prevent new legislation impeding the use of magnetic resonance imaging (MRI) in medical research, diagnosis and treatment, states the European Science Foundation (ESF) in a new report. The report is endorsed by the European Medical Research Councils, representing the medical research communities in 30 countries.
Head and neck abscesses are infrequent complications of upper respiratory infections, but they can occur suddenly and be rapidly progressive. If untreated, the abscesses can lead to airway obstruction, vision loss, intracranial infections, and even death.
ScinoPharm, an active pharmaceutical ingredient specialist, today announced audited record results for its fiscal year 2009. The company posted NT$3.791 billion in revenue, an increase of 20.54% over 2008.
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Abby Jo Lara, APRN 2700 Stanley Gault Pkwy, Suite 129, Louisville, KY 40223-5132 Ph: (270) 326-3949 | Abby Jo Lara, APRN 500 Clinic Dr, Hopkinsville, KY 42240-4991 Ph: (270) 707-3354 |
News Archive
Researchers from the Cochrane Infectious Diseases Group, co-ordinated through the editorial base in LSTM, conducted an independent review of the effects of treating cholera with antimicrobial drugs, published in The Cochrane Library today.
Europe must act to prevent new legislation impeding the use of magnetic resonance imaging (MRI) in medical research, diagnosis and treatment, states the European Science Foundation (ESF) in a new report. The report is endorsed by the European Medical Research Councils, representing the medical research communities in 30 countries.
Head and neck abscesses are infrequent complications of upper respiratory infections, but they can occur suddenly and be rapidly progressive. If untreated, the abscesses can lead to airway obstruction, vision loss, intracranial infections, and even death.
ScinoPharm, an active pharmaceutical ingredient specialist, today announced audited record results for its fiscal year 2009. The company posted NT$3.791 billion in revenue, an increase of 20.54% over 2008.
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.
› Verified 4 days ago
Kayla Brooke Creekmur, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2955 Fort Campbell Blvd, Hopkinsville, KY 42240 Phone: 270-632-1548 | |
Seon Hui Balistrere, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1724 Kenton St Ste 1b, Hopkinsville, KY 42240 Phone: 270-886-8840 | |
Hope B Clark, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1717 High St Ste 4b, Hopkinsville, KY 42240 Phone: 270-887-9058 Fax: 270-997-9341 | |
Amy Michelle Barnes, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1724 Kenton St Ste 1b, Hopkinsville, KY 42240 Phone: 270-886-8840 Fax: 270-886-8869 | |
Mrs. Lauren Ellen Gary, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 270 Burley Ave, Hopkinsville, KY 42240 Phone: 270-887-6767 | |
Lakaya Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 270 Walton Way, Hopkinsville, KY 42240 Phone: 270-886-1919 |